PreveCeutical Medical Inc. (CSE:PREV)

Market Cap	17.60M
Revenue (ttm)	n/a
Net Income (ttm)	-3.12M
Shares Out	586.81M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,061
Average Volume	536,749
Open	0.0250
Previous Close	0.0300
Day's Range	0.0250 - 0.0250
52-Week Range	0.0200 - 0.0600
Beta	0.16
RSI	50.84
Earnings Date	Nov 28, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Stephen Van Deventer
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PREV